The Latest Headlines at American Banking and Market News
International Assets Investment Management LLC Buys New Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN)
International Assets Investment Management LLC bought a new stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the... More of this article »
International Assets Investment Management LLC Invests $1.84 Million in Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI)
International Assets Investment Management LLC purchased a new position in shares of Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI – Free Report) during the fourth quarter, according to the company in its most recent... More of this article »
Power Integrations, Inc. (NASDAQ:POWI) Shares Bought by International Assets Investment Management LLC
International Assets Investment Management LLC grew its holdings in shares of Power Integrations, Inc. (NASDAQ:POWI – Free Report) by 8,102.6% in the 4th quarter, according to its most recent disclosure with the Securities and... More of this article »
International Assets Investment Management LLC Takes $1.80 Million Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
International Assets Investment Management LLC bought a new stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
Haemonetics (NYSE:HAE) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of Haemonetics (NYSE:HAE – Free Report) in a research note issued to investors on Friday, Benzinga reports. HAE has been the subject of several other research... More of this article »
International Assets Investment Management LLC Raises Position in Regions Financial Co. (NYSE:RF)
International Assets Investment Management LLC lifted its position in shares of Regions Financial Co. (NYSE:RF – Free Report) by 1,620.5% during the fourth quarter, according to the company in its most recent filing with the... More of this article »
SPS Commerce’s (SPSC) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of SPS Commerce (NASDAQ:SPSC – Free Report) in a report published on Friday, Benzinga reports. The brokerage currently has a $205.00 price target on the software... More of this article »
Nova (NASDAQ:NVMI) Earns “Hold” Rating from Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of Nova (NASDAQ:NVMI – Free Report) in a research report released on Friday, Benzinga reports. Other analysts have also issued reports about the stock. Evercore... More of this article »
Berry Global Group (NYSE:BERY) Price Target Raised to $81.00 at Bank of America
Berry Global Group (NYSE:BERY – Free Report) had its target price lifted by Bank of America from $74.00 to $81.00 in a report issued on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the industrial... More of this article »
Unity Software (NYSE:U) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Unity Software (NYSE:U – Free Report) in a report issued on Friday morning, Benzinga reports. Needham & Company LLC currently has a $31.00 price target on... More of this article »
EPAM Systems (NYSE:EPAM) Given New $210.00 Price Target at Needham & Company LLC
EPAM Systems (NYSE:EPAM – Free Report) had its price objective decreased by Needham & Company LLC from $350.00 to $210.00 in a report issued on Friday morning, Benzinga reports. Needham & Company LLC currently has a... More of this article »
JFrog (NASDAQ:FROG) PT Lowered to $45.00
JFrog (NASDAQ:FROG – Free Report) had its price objective trimmed by Needham & Company LLC from $55.00 to $45.00 in a research note released on Friday, Benzinga reports. The firm currently has a buy rating on the stock. FROG... More of this article »
Needham & Company LLC Reiterates “Buy” Rating for Avidity Biosciences (NASDAQ:RNA)
Needham & Company LLC reaffirmed their buy rating on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $35.00 target price... More of this article »